AbCellera to present ABCL635 Phase 2 data at 2026 menopause congress

Verifying
  • AbCellera announced a presentation of ABCL635 Phase 2 data.
  • ABCL635 is identified as the subject of the Phase 2 data presentation.
  • The presentation is scheduled for the IMS World Congress on Menopause 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.